Transport and localisation of m-THPC in vitro.
The hydrophobic photosensitising agent meta-tetrahydroxyphenylchlorin (m-THPC) must be formulated with an appropriate vehicle before administration. Studies were carried out with murine leukaemia cells in vitro to assess the role of formulation in drug pharmacokinetics. The rate-limiting step in m-THPC accumulation was the slow conversion of drug aggregates to monomers upon dilution into growth media. Only non-viable cells with damaged membranes showed a rapid drug uptake, otherwise m-THPC accumulation was a slow process. It was found that m-THPC was localised mainly at mitochondrial loci. Subsequent irradiation resulted in the release of cytochrome c into the cytosol, triggering a rapid activation of caspase-3, which led to an apoptotic response. Plasma distribution of m-THPC involved binding to lipoprotein species, with only a slight appearance of the drug in the albumin fraction.